Literature DB >> 9575138

p53 inhibits hypoxia-inducible factor-stimulated transcription.

M V Blagosklonny1, W G An, L Y Romanova, J Trepel, T Fojo, L Neckers.   

Abstract

p53 is required for hypoxia-induced apoptosis in vivo, although the mechanism by which this occurs is not known. Conversely, induction of the hypoxia-inducible factor-1 (HIF-1) transactivator stimulates transcription of a number of genes crucial to survival of the hypoxic state. Here we demonstrate that p53 represses HIF-1-stimulated transcription. Although higher levels of p53 are required to inhibit HIF than are necessary to transcriptionally activate p53 target genes, these levels of p53 are similar to those that stimulate cleavage of poly(ADP-ribose) polymerase, an early event in apoptosis. Transfection of full-length p300 stimulates both p53-dependent and HIF-dependent transcription but does not relieve p53-mediated inhibition of HIF. In contrast, a p300 fragment, which binds to p53 but not to HIF-1, prevents p53-dependent repression of HIF activity. Transcriptionally inactive p53, mutated in its DNA binding domain, retains the ability to block HIF transactivating activity, whereas a transcriptionally inactive double point mutant defective for p300 binding does not inhibit HIF. Finally, depletion of doxorubicin-induced endogenous p53 by E6 protein attenuates doxorubicin-stimulated inhibition of HIF, suggesting that a p53 level sufficient for HIF inhibition can be achieved in vivo. These data support a model in which stoichiometric binding of p53 to a HIF/p300 transcriptional complex mediates inhibition of HIF activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575138     DOI: 10.1074/jbc.273.20.11995

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.

Authors:  Kenzo Ohara; Takayuki Ohkuri; Takumi Kumai; Toshihiro Nagato; Yui Nozaki; Kei Ishibashi; Akemi Kosaka; Marino Nagata; Shohei Harabuchi; Mizuho Ohara; Kensuke Oikawa; Naoko Aoki; Yasuaki Harabuchi; Esteban Celis; Hiroya Kobayashi
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

Review 2.  p53 regulation of metabolic pathways.

Authors:  Eyal Gottlieb; Karen H Vousden
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-02       Impact factor: 10.005

Review 3.  Therapeutic targets for hypoxia-elicited pathways.

Authors:  C T Taylor; S P Colgan
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

4.  Identification of long noncoding RNAs involved in adaptability to chronic hypoxic by whole transcriptome sequencing.

Authors:  Zengrong Zhang; Mohan Qiu; Huarui Du; Qingyun Li; Chunlin Yu; Wu Gan; Han Peng; Bo Xia; Xia Xiong; Xiaoyan Song; Li Yang; Chenming Hu; Jialei Chen; Chaowu Yang; Xiaosong Jiang
Journal:  3 Biotech       Date:  2020-05-27       Impact factor: 2.406

Review 5.  Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

Authors:  Stefan Kaluz; Milota Kaluzová; Shu-Yuan Liao; Michael Lerman; Eric J Stanbridge
Journal:  Biochim Biophys Acta       Date:  2009-01-22

Review 6.  Hypoxic preconditioning protects against ischemic brain injury.

Authors:  Frank R Sharp; Ruiqiong Ran; Aigang Lu; Yang Tang; Kenneth I Strauss; Todd Glass; Tim Ardizzone; Myriam Bernaudin
Journal:  NeuroRx       Date:  2004-01

7.  Hypoxia-inducible factor-1 mediates adaptive developmental plasticity of hypoxia tolerance in zebrafish, Danio rerio.

Authors:  Cayleih E Robertson; Patricia A Wright; Louise Köblitz; Nicholas J Bernier
Journal:  Proc Biol Sci       Date:  2014-07-07       Impact factor: 5.349

8.  Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53.

Authors:  Lars O Hansson; Assaf Friedler; Stefan Freund; Stefan Rudiger; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-17       Impact factor: 11.205

9.  p53 regulates renal expression of HIF-1{alpha} and pVHL under physiological conditions and after ischemia-reperfusion injury.

Authors:  Timothy A Sutton; Jared Wilkinson; Henry E Mang; Nicole L Knipe; Zoya Plotkin; Maya Hosein; Katelyn Zak; Jeremy Wittenborn; Pierre C Dagher
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-24

10.  Down-regulation of Jab1, HIF-1alpha, and VEGF by Moloney murine leukemia virus-ts1 infection: a possible cause of neurodegeneration.

Authors:  Gina F Lungu; George Stoica; Paul K Y Wong
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.